Alexion Pharmaceuticals, Inc.

Erste Asset Management GmbH ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

11/25/2024

Shares

53,000

Value ($000)

9,768

Weight

0.2%

2018 Q4 - 2021 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	11/25/2024	9,768	0.2%	53,000	6/30/2021
2021 Q1	11/25/2024	8,846	0.2%	57,650	3/31/2021
2020 Q4	11/25/2024	8,956	0.2%	57,650	12/31/2020
2020 Q3	11/25/2024	7,979	0.3%	70,950	9/30/2020
2020 Q2	11/22/2024	7,891	0.3%	70,950	6/30/2020
2020 Q1	11/22/2024	6,191	0.4%	70,950	3/31/2020
2019 Q4	11/22/2024	8,733	0.4%	80,450	12/31/2019
2019 Q3	11/22/2024	7,259	0.4%	74,250	9/30/2019
2019 Q2	11/22/2024	9,365	0.5%	74,250	6/30/2019
2019 Q1	11/22/2024	9,349	0.5%	70,150	3/31/2019
2018 Q4	11/26/2024	6,882	0.5%	70,150	12/31/2018